Medigene AG (FRA:MDG1)
Germany · Delayed Price · Currency is EUR 0.0436
+0.0006 (1.40%)
Jan 30, 2026, 12:10 PM CET
Medigene AG Company Description
Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.
Medigene AG
| Country | Germany |
| Founded | 1994 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 87 |
| CEO | Ralph Schafer |
Contact Details
Address: Lochhamer Strasse 11 Munich, 82152 Germany | |
| Phone | 49 89 2000 330 |
| Website | medigene.com |
Stock Details
| Ticker Symbol | MDG1 |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A1X3W00 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ralph Schafer | Chief Executive Officer |
| Birger Kohlert | Chief Financial Officer |
| Pamela Keck | Head of Investor Relations |